✦ LIBER ✦

Hyperinsulinaemia reduces the 24-h virological response to PEG-interferon therapy in patients with chronic hepatitis C and insulin resistance

✍ Scribed by G. Bortoletto; L. Scribano; S. Realdon; M. Marcolongo; S. Mirandola; L. Franceschini; S. Bonisegna; F. Noventa; M. Plebani; D. Martines; A. Alberti

Book ID: 108886354
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 95 KB
Volume: 17
Category: Article
ISSN: 1352-0504
DOI: 10.1111/j.1365-2893.2009.01204.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2′-,5′-Oligoadenylate synthetase respons

2′-,5′-Oligoadenylate synthetase response ratio predicting virological response to PEG-interferon-α2b plus ribavirin therapy in patients with chronic hepatitis C

✍ K.-I. Kim; S.-R. Kim; N. Sasase; M. Taniguchi; S. Harada; K. Kinoshita; S.-H. Ki 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 549 KB

Optimal follow-up time to determine the

Optimal follow-up time to determine the sustained virological response in patients with chronic hepatitis C receiving pegylated-interferon and ribavirin

✍ Masashi Namikawa; Satoru Kakizaki; Yutaka Yata; Yuichi Yamazaki; Norio Horiguchi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

Long-term follow-up of chronic hepatitis

Long-term follow-up of chronic hepatitis C patients with sustained virological response to various forms of interferon-based anti-viral therapy

✍ E. FORMANN; P. STEINDL-MUNDA; H. HOFER; W. JESSNER; U. BERGHOLZ; C. GURGUTA; P. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Mutations in the interferon sensitivity

Mutations in the interferon sensitivity determining region and virological response to combination therapy with pegylated-interferon alpha 2b plus ribavirin in patients with chronic hepatitis C-1b infection

✍ Mina Nakagawa; Naoya Sakamoto; Mayumi Ueyama; Kaoru Mogushi; Satoshi Nagaie; Yas 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 266 KB

Risk factors for the development of hepa

Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy

✍ HAJIME TOKITA; HIDEO FUKUI; AKIHISA TANAKA; HIROSHI KAMITSUKASA; MICHIYASU YAGUR 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

Reduced risk of hepatocellular carcinoma

Reduced risk of hepatocellular carcinoma after interferon therapy in aged patients with chronic hepatitis C is limited to sustained virological responders

✍ Y. Imai; S. Tamura; H. Tanaka; N. Hiramatsu; S. Kiso; Y. Doi; M. Inada; T. Nagas 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB